ArticleProceedings of the National Academy of Sciences of the United States of America2023

Proxalutamide reduces SARS-CoV-2 infection and associated inflammatory response.

Yuanyuan Qiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.